GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in GeoVax Labs, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −1 vs. Q1 2023
- Shares held
- 1.61M
- +3.96K (+0.2%) vs. Q1 2023
- Total value
- $886.0K
- −$182.6K (−17.1%) vs. Q1 2023
- New holders
- 2
- 2 more added
- Sold out
- 3
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 730,985 | $402.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 413,444 | $227.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 172,750 | $95.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 97,942 | $53.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 50,197 | $27.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 36,805 | $20.2K | 0.00% | +20,716+128.8% | Added |
| Northern Trust Corp | 34,214 | $18.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 27,097 | $15.0K | 0.00% | +27,097 | New |
| Welch & Forbes LLC | 16,994 | $9.35K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 11,328 | $6.00K | 0.00% | +11,328 | New |
| Tower Research Capital LLC (TRC) | 10,562 | $5.81K | 0.00% | −194−1.8% | Reduced |
| Wells Fargo & Company | 4,690 | $2.58K | 0.00% | +128+2.8% | Added |
| Advisor Group Holdings, Inc. | 3,000 | $1.65K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 725 | $399 | 0.00% | −13,874−95.0% | Reduced |
| Global Retirement Partners, LLC | 401 | $221 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −27,360−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,383−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |